Cayston Approval History
FDA Approved: Yes (First approved February 22, 2010)
Brand name: Cayston
Generic name: aztreonam lysine
Dosage form: Inhalation Solution
Company: Gilead Sciences, Inc.
Treatment for: Pneumonia with Cystic Fibrosis
Cayston (aztreonam lysine for inhalation) is an inhaled anti-pseudomonal therapy for people with cystic fibrosis (CF) who have pulmonary Pseudomonas aeruginosa infection.
Development History and FDA Approval Process for Cayston
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.